EXAS
Exact Sciences Corporation
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$104.91
+0.00%Margins
Gross margin
69.7%
EBITDA margin
1.3%
EBIT margin
-6.2%
Net margin
-6.4%
FCF margin
11.0%
-8.7%
Return on equity
-3.5%
Return on assets
-4.1%
Return on invested capital
0.55x
Asset turnover
$491.4M
Cash from operations
$5.05
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025